Denmark· DK-28105933917
Colestyramin "Orifarm"
A colestyramine product containing colestyramin, registered in Denmark by Orifarm Generics A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Colestyramine is registered in 13 of 19 countries.
Countries holding a registration under ATC C10AC01 (colestyramine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Colestyramine · ATC C10AC01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- COLESTYRAMIN
- Manufacturer
- Orifarm Generics A/S
- Country
- Denmark (DK)
- ATC code
- C10AC01
- ATC class
- Colestyramine
- Defined daily dose
- 14 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105933917
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
88 interactions on record for colestyramine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Colestyramine · interactions on record
88 records
- 3 severe
- 73 moderate
- 7 minor
Most severe, free to view
- Mycophenolic acidL04AA06severe
- TeriflunomidL04AA31severe
- TeriflunomideL04AK02severe
- Chenodeoxycholic acidA05AA01moderate
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C10AC01
Colestyramine, as other registers publish it.
- United StatesCholestyraminePar Health USA, LLC
- United StatesCholestyraminePar Health USA, LLC
- United StatesCHOLESTYRAMINEEPIC PHARMA, LLC
- United StatesCHOLESTYRAMINE LIGHTEPIC PHARMA, LLC
- CanadaCHOLESTYRAMINE-ODANODAN LABORATORIES LTD
- GermanyColestyramin 1 A Pharma1 A Pharma Gmbh
- NorwayColestyramin orifarmOrifarm Generics A/S
- NorwayColestyramin ratiopharmRatiopharm
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0ff8911-d39c-459d-a53b-855ebdd31a83 GET /v1/drugs/e0ff8911-d39c-459d-a53b-855ebdd31a83?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til oral suspension, enkeltdosisbeholder",
"source": "dkma",
"strength": "4 g",
"auth_role": "DKMA",
"dk_drugid": "28105933917",
"substance": "COLESTYRAMIN",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "43279"
}See everything about colestyramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.